Neuroblastoma | CHOP Research Institute
 

Neuroblastoma

Cornerstone Blog

Uncovering the Genetic Connection Between Birth Defects and Childhood Cancers

Published on
Dec 5, 2024
At the Intersection of Birth Defects and Childhood Cancers
CHOP researchers are looking to enhance the understanding of the possible genetic links between childhood cancers and structural birth defects.
Cornerstone Blog

Excellence Award, Orphan Drug Designation, Imaging Technique, Coordinated Asthma Care

Published on
Nov 22, 2024
Excellence Award, Rare Disease, Orthopedic Ultrasound
Congratulations to physician scientist Dr. Yael Mosse, who received a Penn Medicine Award of Excellence for her contributions to pediatric oncology, and more.
Cornerstone Blog

Could DLK1 Be an Immunotherapeutic Target to Treat Neuroblastoma?

Published on
Nov 6, 2024
DLK1 Potential Immunotherapeutic Target for Neuroblastoma
Researchers identify cell surface protein DLK1 as a potential immunotherapeutic target for neuroblastoma.
Cornerstone Blog

Hyundai Hope On Wheels Supports Neuroblastoma Research at CHOP

Published on
Oct 30, 2024
Hyundai Hope On Wheels Supports Neuroblastoma Research
Adam Wolpaw, MD, PhD, and Timothy Spear, MD, PhD, have been awarded grants from Hyundai Hope On Wheels to improve CAR T-cell therapy.
Cornerstone Blog

CHOP Among Best Hospitals, Opioid Rx Rates, Ronald McDonald House Honors

Published on
Oct 11, 2024
CHOP Named a Top Hospital by U.S. News & World Report
In The News this week, we celebrate CHOP being named a top children’s hospitals in the nation for the 17th consecutive year.
Esther R. Berko, MD, PhD
Esther R. Berko, MD, PhD

Dr. Berko is a physician scientist at Children's Hospital of Philadelphia and Schneider Children's Medical Center of Israel. Dr. Berko specializes in pediatric solid tumors, and studies genomic and epigenomic evolution in these cancers to develop novel diagnostic and therapeutic interventions.

E-mail:
berkoe [at] chop.edu
Cornerstone Blog

Neuroblastoma Targets, Pediatric Scientist Development Program, Genetic Epilepsy

Published on
Aug 16, 2024
Neuroblastoma Targets, Pediatric Scientist Development Program
Two CHOP fellows join the Pediatric Scientist Development Program, AI offers timely diagnosis of genetic epilepsies, and more in this week’s news.

Afamitresgene Autoleucel in Pediatric Subjects with MAGE-A4 Positive Tumors

Afamitresgene Autoleucel in Pediatric Subjects with MAGE-A4 Positive Tumors

This study involves an investigational cellular therapy called Afamitresgene Autoleucel.

Cornerstone Blog

Cystic Fibrosis Research, Pitcher of Hope Award, Kidney Stones, Adolescent Health

Published on
Jun 7, 2024
Cystic Fibrosis Research, Kidney Stones, Adolescent Health
CHOP receives a collaborative grant to drive cystic fibrosis research forward, Dr. John Maris honored with Pitcher of Hope Award, and more.

GD2CART for Osteosarcoma or Neuroblastoma

This study enrolls patients that have been diagnosed with osteosarcoma or neuroblastoma that has come back (relapsed) or has not responded to standard treatments (refractory).